Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2018Biology of Blood and Marrow TransplantationOpen Access

Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era

View Full Paper
Ask AI
Bookmark
Share

Authors

YXYu‐juan XuePeking UniversityYCYifei ChengPeking UniversityALAidong LuUniversity of North Carolina at Charlotte

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xue et al. (2018) studied this question.

synapsesocial.com/papers/6a1069cb28c2d29469fe7576https://doi.org/10.1016/j.bbmt.2018.12.007
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome‐positive acute lymphoblastic leukemia2014 · 79 citations
  2. 2The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 19972000 · 417 citations
  3. 3Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia2000 · 601 citations
  4. 4World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 19971999 · 3,290 citations
  5. 5Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study2012 · 336 citations